Baricitinib attenuates the proinflammatory phase of covid-19 driven by lung-infiltrating monocytes

HIGHLIGHTS

• who: Brian Dobosh from the Emory University of Medicine, Atlanta, GA, USA have published the Article: Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes, in the Journal: (JOURNAL) of June/14,/2022
• what: Similarly, lung-infiltrating monocytes in the model , which were not directly infected but rather were made to cross an infected epithelium, also contained SARS-CoV-2 genome copies, as determined by qRT-PCR . Critically, the authors show that virus-laden, IL-1b- and CXCL8-positive monocytes are also present in_vivo in the lung fluid of patients with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.